Our mission is to provide reliable, scientifically-backed information on treatments for Long COVID, ensuring that individuals have access to the most current and effective medical strategies. We are dedicated to sifting through the latest research to present only the treatments with proven efficacy, helping those affected make informed decisions about their health.

We aim to enhance public understanding and awareness of Long COVID, its impacts, and treatment options. Through education and outreach, our mission is to help people with Long COVID navigate upcoming treatment options backed by scientifically-backed evidence.

Our goal is to bridge the gap between those suffering from Long COVID and the treatments available. We strive to facilitate easier access to hard-to-obtain therapeutics and provide rationale for using them based on the latest scientific research and on-going clinical trials.

Expanded Access is one powerful way patients and their physicians can request access to experimental treatments outside of a clinical trial.

We are committed to promoting and supporting the expansion and funding of clinical trials for Long COVID treatments. By partnering with research institutions, drug manufacturers, and encouraging participant enrollment, our mission is to contribute to the development of new, effective therapies and enhance our understanding of this condition.

Our mission is to advocate for policy changes that support the needs of individuals with Long COVID. We aim to work with policymakers to ensure that Long COVID is recognized in healthcare policies, insurance coverage is expanded, and more resources are allocated for research and treatment options.